• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Synthesis of a novel pentasaccharide core component from the lipooligosaccharide of Moraxella catarrhalis

    Author(s)
    Pearson, Andrew G
    Peak, Ian R
    Wilson, Jennifer C
    Grice, I Darren
    Griffith University Author(s)
    Grice, Darren D.
    Wilson, Jenny C.
    Peak, Ian
    Pearson, Andrew G.
    Year published
    2011
    Metadata
    Show full item record
    Abstract
    The novel pentasaccharide [p-(trifluoroacetamido)phenyl]ethyl 3-O-b-D-glucopyranosyl-4-O-b-D-glucopyranosyl-6-O-[2-O-(a-D-glucopyranosyl)-b-D-glucopyranosyl]-a-D-glucopyranoside (1), which includes a linker moiety to enable facile coupling to an antigenic protein, was synthesised as a component of a potential vaccine candidate against the Gram-negative bacterium Moraxella catarrhalis. This microorganism is one of three principal causative agents of otitis media in children. The pentasaccharide represents a common cross-serotype (A, B and C) structure from the lipooligosaccharides of Moraxella catarrhalis.The novel pentasaccharide [p-(trifluoroacetamido)phenyl]ethyl 3-O-b-D-glucopyranosyl-4-O-b-D-glucopyranosyl-6-O-[2-O-(a-D-glucopyranosyl)-b-D-glucopyranosyl]-a-D-glucopyranoside (1), which includes a linker moiety to enable facile coupling to an antigenic protein, was synthesised as a component of a potential vaccine candidate against the Gram-negative bacterium Moraxella catarrhalis. This microorganism is one of three principal causative agents of otitis media in children. The pentasaccharide represents a common cross-serotype (A, B and C) structure from the lipooligosaccharides of Moraxella catarrhalis.
    View less >
    Journal Title
    Carbohydrate Research
    Volume
    346
    Issue
    17
    DOI
    https://doi.org/10.1016/j.carres.2011.10.002
    Subject
    Medicinal and biomolecular chemistry
    Medicinal and biomolecular chemistry not elsewhere classified
    Organic chemistry
    Organic chemistry not elsewhere classified
    Biochemistry and cell biology
    Publication URI
    http://hdl.handle.net/10072/42583
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander